Radio Advisory’s Rachel Woods sat down with Advisory Board experts Gaby Marmolejos and Madeline Vogel to share the latest on bariatric surgery volumes, coverage decisions, patient preferences, drug shortages, compounding, and the new competitive landscape for direct-to-consumer obesity care. Marmolejos noted the dramatic rise of GLP-1 medications and the trend’s effect on the market. “About 6% of U.S. adults are using GLP-1s today, compared to less than 1% prior to 2019,” Marmolejos said. This surge in GLP-1 usage has created long waitlists at weight management clinics and has directly impacted bariatric surgery volumes, as many eligible patients now prefer pharmacological options.
Read the full article: Obesity Care Today: Drugs, Surgeries, and Coverage Decisions //
Source: https://www.advisory.com/daily-briefing/2025/05/20/radio-advisory-248